Influence of the COVID-19 Pandemic on Overall Physician Visits and Telemedicine Use Among Patients With Type 1 or Type 2 Diabetes in Japan-Reference-Cited by-同舟云学术

Influence of the COVID-19 Pandemic on Overall Physician Visits and Telemedicine Use Among Patients With Type 1 or Type 2 Diabetes in Japan

Published:2022-10-05 Issue:10 Volume:32 Page:476-482
ISSN:0917-5040
Container-title:Journal of Epidemiology
language:en
Short-container-title:Journal of Epidemiology

Author:

Yagome Susumu¹,Sugiyama Takehiro²,Inoue Kosuke³,Igarashi Ataru⁴,Bouchi Ryotaro⁵,Ohsugi Mitsuru²,Ueki Kohjiro²,Goto Atsushi¹^ORCID

Affiliation:

1. Department of Health Data Science, Yokohama City University Graduate School of Data Science

2. Diabetes and Metabolism Information Centre, National Centre for Global Health and Medicine

3. Department of Social Epidemiology, Graduate School of Medicine, Kyoto University

4. Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, the University of Tokyo

5. Department of Diabetes, Endocrinology and Metabolism, National Centre for Global Health and Medicine

Publisher

Japan Epidemiological Association

Subject

General Medicine,Epidemiology

Link

https://www.jstage.jst.go.jp/article/jea/32/10/32_JE20220032/_pdf

Reference25 articles.

1. 1. Charvat H, Goto A, Goto M, et al. Impact of population aging on trends in diabetes prevalence: a meta-regression analysis of 160,000 Japanese adults. J Diabetes Investig. 2015;6:533–542.

2. 2. Ministry of Health L and W. National Health and Nutrition Survey, Tokyo: Ministry of Health, Labour and Welfare, 2019. Published online 2020:0–40. https://www.mhlw.go.jp/stf/newpage_14156.html.

3. 3. Peric S, Stulnig TM. Diabetes and COVID-19: Disease-Management-People. Wien Klin Wochenschr. 2020;132(13–14):356–361. Published online May 2020.

4. 4. National Institute of Health and Nutrition. Health Japan 21 (the second term). https://www.nibiohn.go.jp/eiken/kenkounippon21/en/index.html.

5. 5. Mitsuya H. Fight against COVID-19 but avoid disruption of services for other communicable diseases (CDs) and noncommunicable diseases (NCDs). Glob Health Med. 2020 Dec 31;2(6):343–345.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in prescription days and intervals between physician visits and their impact on glycemic control before and during the COVID-19 pandemic in Japan;GHM Open;2024-07-26

2. Impact of the State of Emergency Declaration for Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic Suppression on Individuals with Type 1 Diabetes Mellitus;Internal Medicine;2024-05-01

3. Heterogeneity of the effect of the COVID-19 pandemic on the incidence of Metabolic Syndrome onset at a Japanese campus;PeerJ;2024-04-05

4. Evaluation of assessable telemedicine in patients with rheumatoid arthritis: A systematic review;International Journal of Rheumatic Diseases;2024-01

5. Understanding impacts of COVID-19 restrictions on glycemic control for patients with diabetes in Japan;Journal of Diabetes & Metabolic Disorders;2023-09-21